Metabolic characterization of directly reprogrammed renal tubular epithelial cells (iRECs)

Fibroblasts can be directly reprogrammed to induced renal tubular epithelial cells (iRECs) using four transcription factors. These engineered cells may be used for disease modeling, cell replacement therapy or drug and toxicity testing. Direct reprogramming induces drastic changes in the transcriptional landscape, protein expression, morphological and functional properties of cells. However, how the metabolome is changed by reprogramming and to what degree it resembles the target cell type remains unknown. Using untargeted gas chromatography-mass spectrometry (GC-MS) and targeted liquid chromatography-MS, we characterized the metabolome of mouse embryonic fibroblasts (MEFs), iRECs, mIMCD-3 cells, and whole kidneys. Metabolic fingerprinting can distinguish each cell type reliably, revealing iRECs are most similar to mIMCD-3 cells and clearly separate from MEFs used for reprogramming. Treatment with the cytotoxic drug cisplatin induced typical changes in the metabolic profile of iRECs commonly occurring in acute renal injury. Interestingly, metabolites in the medium of iRECs, but not of mIMCD-3 cells or fibroblast could distinguish treated and non-treated cells by cluster analysis. In conclusion, direct reprogramming of fibroblasts into renal tubular epithelial cells strongly influences the metabolome of engineered cells, suggesting that metabolic profiling may aid in establishing iRECs as in vitro models for nephrotoxicity testing in the future.

[1]  E. Kováts,et al.  Gas‐chromatographische Charakterisierung organischer Verbindungen. Teil 1: Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone , 1958 .

[2]  R. Safirstein,et al.  Uptake and metabolism of cisplatin by rat kidney. , 1984, Kidney international.

[3]  A. Kitagawa,et al.  Protective effect of N-benzoyl-beta-alanine against cisplatin nephrotoxicity in rats. , 1996, Renal failure.

[4]  S. Stein.  An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data , 1999 .

[5]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[6]  J. Megyesi,et al.  Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure. , 2002, Kidney international.

[7]  C. Rudin,et al.  Genotoxic exposure is associated with alterations in glucose uptake and metabolism. , 2002, Cancer research.

[8]  R. Schnellmann,et al.  Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. , 2002, The Journal of pharmacology and experimental therapeutics.

[9]  J. Megyesi,et al.  Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure , 2002 .

[10]  D. Townsend,et al.  Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells. , 2003, Journal of the American Society of Nephrology : JASN.

[11]  Robert A. Harris,et al.  PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity. , 2004, American journal of physiology. Renal physiology.

[12]  T. Ludwig,et al.  Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. , 2005, The American journal of pathology.

[13]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[14]  Yves Gibon,et al.  GMD@CSB.DB: the Golm Metabolome Database , 2005, Bioinform..

[15]  G. Kaushal,et al.  Fibrate prevents cisplatin-induced proximal tubule cell death. , 2005, Kidney international.

[16]  J. Megyesi,et al.  Metabolomic study of cisplatin-induced nephrotoxicity. , 2006, Kidney international.

[17]  A. C. Santos,et al.  Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria , 2007, Archives of Toxicology.

[18]  D. Portilla,et al.  Metabolomics as an extension of proteomic analysis: study of acute kidney injury. , 2007, Seminars in nephrology.

[19]  R. L. Brown,et al.  Development of a database of gas chromatographic retention properties of organic compounds. , 2007, Journal of chromatography. A.

[20]  G. Ramesh,et al.  Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. , 2007, Kidney international.

[21]  Mark P. Styczynski,et al.  Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. , 2007, Analytical chemistry.

[22]  Paul Jennings,et al.  hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. , 2008, American journal of physiology. Renal physiology.

[23]  Xiao-Ming Yin,et al.  Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. , 2008, Kidney international.

[24]  Abraham Nyska,et al.  Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity , 2009, Toxicologic pathology.

[25]  David S. Wishart,et al.  MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..

[26]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[27]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[28]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[29]  G. Ramesh,et al.  Mechanisms of Cisplatin Nephrotoxicity , 2010, Toxins.

[30]  Andre Terzic,et al.  Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. , 2011, Cell metabolism.

[31]  Jianguo Xia,et al.  Metabolomic Data Processing, Analysis, and Interpretation Using MetaboAnalyst , 2011, Current protocols in bioinformatics.

[32]  Jianguo Xia,et al.  Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst , 2011, Nature Protocols.

[33]  I. Park,et al.  Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. , 2011, Kidney international.

[34]  Laurent Vergnes,et al.  UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells , 2011, The EMBO journal.

[35]  Ross Ward,et al.  United States Renal Data System , 2011 .

[36]  O. Fiehn,et al.  Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism , 2012, PloS one.

[37]  S. Kersten,et al.  Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury. , 2012, American journal of physiology. Renal physiology.

[38]  S. Zhuang,et al.  Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR/PI3K signaling , 2012, Journal of cellular physiology.

[39]  R. Vahdani,et al.  Vitamin B6 dose-dependently ameliorates renal hemodynamic toxicity of cisplatin in rat model of nephrotoxicity: the histopathologic and biochemical findings , 2014, Comparative Clinical Pathology.

[40]  Juan Carlos Izpisua Belmonte,et al.  The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming , 2011, Cell Research.

[41]  関谷 明香,et al.  Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors , 2012 .

[42]  David S. Wishart,et al.  MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis , 2012, Nucleic Acids Res..

[43]  C. Birkemeyer,et al.  Comparison of extraction conditions and normalization approaches for cellular metabolomics of adherent growing cells with GC-MS , 2012 .

[44]  M. Takasato,et al.  Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. , 2013, Journal of the American Society of Nephrology : JASN.

[45]  H. Haller,et al.  In Vivo and In Vitro Analysis of Age-Associated Changes and Somatic Cellular Senescence in Renal Epithelial Cells , 2014, PloS one.

[46]  Samantha A. Morris,et al.  CellNet: Network Biology Applied to Stem Cell Engineering , 2014, Cell.

[47]  H. Yamada,et al.  Identification of metabolomic biomarkers for drug‐induced acute kidney injury in rats , 2014, Journal of applied toxicology : JAT.

[48]  E. Stanley,et al.  Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney , 2013, Nature Cell Biology.

[49]  C. Edelstein,et al.  Pathophysiology of Cisplatin-Induced Acute Kidney Injury , 2014, BioMed research international.

[50]  Ying Zhang,et al.  Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. , 2014, Cell stem cell.

[51]  D. Zink,et al.  Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells. , 2014, Molecular pharmaceutics.

[52]  Hyobin Jeong,et al.  Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation , 2015, PloS one.

[53]  Jing Zhou,et al.  Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids , 2015, Nature Communications.

[54]  Benjamin S. Freedman,et al.  Nephron organoids derived from human pluripotent stem cells model kidney development and injury , 2015, Nature Biotechnology.

[55]  Stephan Aiche,et al.  Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[56]  David S. Wishart,et al.  MetaboAnalyst 3.0—making metabolomics more meaningful , 2015, Nucleic Acids Res..

[57]  Leif Oxburgh,et al.  A synthetic niche for nephron progenitor cells. , 2015, Developmental cell.

[58]  Robert G. Parton,et al.  Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2016, Nature.

[59]  Jianguo Xia,et al.  Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis , 2016, Current protocols in bioinformatics.

[60]  O. Kretz,et al.  Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors , 2016, Nature Cell Biology.

[61]  I. Pastan,et al.  3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors. , 2016, Cell stem cell.

[62]  Fengguo Xu,et al.  Discovery of Potential Biomarkers with Dose- and Time-Dependence in Cisplatin-Induced Nephrotoxicity Using Metabolomics Integrated with a Principal Component-Based Area Calculation Strategy. , 2016, Chemical research in toxicology.

[63]  Sharmistha Banerjee,et al.  Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses. , 2016, BioFactors.

[64]  Fengguo Xu,et al.  Branched-Chain Amino Acids as Predictors for Individual Differences of Cisplatin Nephrotoxicity in Rats: A Pharmacometabonomics Study. , 2017, Journal of proteome research.

[65]  S. Moon,et al.  Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells. , 2017, Stem cells and development.

[66]  Wei Li,et al.  Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats , 2017, Scientific Reports.